Mstyslav Chernov
Oscar-Winning Documentarian and Pulitzer Prize Journalist
Founding Director, Wake Forest Institute for Regenerative Medicine | Creator of the First 3D Bioprinter | Chair, ACS Board of Regents | 800+ Publications & 250+ Patents
Anthony Atala is the scientist who grew a human organ in a lab and printed human tissue with a 3D printer — and then implanted them in patients. As founding director of the world's leading regenerative medicine institute, he brings audiences face-to-face with a future where organ shortages are solved and damaged tissues are repaired with the body's own cells. His TED talk has captivated millions.
Want to book Anthony Atala as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Healthcare speaker Anthony Atala is the founding Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), the George Link Jr. Professor of Urology, and Chair of the Department of Urology at Wake Forest University School of Medicine. He is widely regarded as the world’s foremost pioneer in regenerative medicine — the science of repairing and replacing damaged human tissues and organs using the body’s own cells — and has spent decades turning what once seemed like science fiction into clinical reality.
Keynote speaker Anthony Atala leads a team of more than 450 physicians, researchers, and engineers working on over 40 different tissues and organs. His laboratory has produced 16 clinical applications of cell and tissue therapy technologies that have been used in human patients — including skin, bladders, urethras, cartilage, muscle, and vaginal organs — making WFIRM the most clinically productive regenerative medicine institute in the world. Atala is the creator of the Integrated Tissue and Organ Printing System (ITOP), the first 3D bioprinter capable of producing human-scale tissue constructs. His team developed the first lab-grown organ — a bladder — ever successfully implanted into a human being, a milestone recognized twice by Time magazine as one of the top ten medical breakthroughs of the year. More recently, his kidney research team was awarded the prestigious $1 million KidneyX Prize for a breakthrough 3D kidney construct platform with the potential to address the global organ transplant shortage.
Atala’s credentials span science, surgery, and institutional leadership at the highest levels. He has published over 800 peer-reviewed journal articles, holds more than 250 national and international patents, and has edited 25 books including Principles of Regenerative Medicine and 3D Biofabrication. He is a member of the National Academy of Sciences’ Institute of Medicine, a charter fellow of the National Academy of Inventors, and a member of the American Institute for Medical and Biological Engineering. He was elected Chair of the Board of Regents of the American College of Surgeons — one of the most prestigious governance roles in surgery — following a career of service to the NIH, the National Cancer Institute’s Advisory Board, and the Armed Forces Institute of Regenerative Medicine. WFIRM was also awarded a landmark up to $160 million NSF Engines grant to build a regional regenerative medicine innovation hub, cementing the institute’s role as a national driver of the field.
As a speaker, Anthony Atala offers audiences a rare combination of visionary science and clinical proof. Where others forecast what bioprinting might one day achieve, Atala has already done it — in the operating room, with real patients. His TED talk on printing a human kidney has captivated millions worldwide, and his keynotes translate that same clarity and wonder into the urgent questions facing healthcare, biotech, and innovation leaders: how do we solve the organ shortage crisis, what will medicine look like when we can grow tissues on demand, and how do we build the policy and investment frameworks to get there? Organizations book Anthony Atala when they need a speaker who doesn’t just inspire — he proves.
Atala takes audiences inside the world's most advanced regenerative medicine laboratory, where over 40 tissues and organs are in active development and 16 technologies have already been used in human patients. This keynote covers the science, milestones, and remaining frontiers of regenerative medicine — from lab-grown bladders and skin to the quest for printable kidneys and hearts — and what it means for the future of healthcare, aging, and quality of life.
The ability to print living human tissue on demand is no longer theoretical — it is happening in Atala's laboratory today. This keynote explores how 3D bioprinting works, the engineering breakthroughs that made it possible, and the clinical and commercial implications for hospitals, pharmaceutical companies, medical device manufacturers, and health systems. Atala addresses both the extraordinary promise and the regulatory, ethical, and infrastructure challenges that will define the industry's trajectory.
Over 100,000 people in the United States alone are on organ transplant waiting lists at any given time. Atala explores the full landscape of solutions — from bioengineered organs and 3D printing to xenotransplantation and cell therapies — and what it will take to move from promising research to population-scale impact. This talk is designed for healthcare executives, policymakers, and investors who need to understand where the field is going and how to help accelerate it.
Behind every medical breakthrough is a system — of funding, collaboration, risk tolerance, and translation from bench to bedside. Atala draws on his experience building WFIRM into the world's leading regenerative medicine institute to offer a practical framework for driving innovation in complex, high-stakes fields. This keynote is equally relevant for corporate R&D leaders, academic institutions, and government science agencies seeking to turn research investment into real-world outcomes.
| Basic Data Protection Information | |
|---|---|
| Data controller | AURUM SPEAKERS BUREAU S.L. |
| Address | Parc Audiovisual de Catalunya 1, Oficina S11, 08225 Terrassa, Spain |
| Purposes | We will use your data to respond to your requests and deliver our services to you. |
| Marketing | We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Lawful basis | We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Recipients | Generally, only our members of staff who have been duly authorised may access the data that you have provided. |
| Your Rights | You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website. |
| Additional Information | For more information, please see “PRIVACY POLICY” on our website. |